Goldman Sachs Highlights BioNTech’s (BNTX) Immuno-Oncology and ADC Pipeline

30 1 月, 2026

One Min Read

7 Views

原文: https://finance.yahoo.com/news/goldman-sachs-highlights-biontech-bntx-070714973.html

Last Update: 30 1 月, 2026

Written By

Other Articles

Previous

Stifel Sees Sportradar (SRAD) as Buy Amid Rational Sports Betting Duopoly

Next

Citizens Highlights BeOne Medicines’ (ONC) $3.8B Revenue Potential for 2025

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept